The current earnings forecast score of Danaher Corp is 8.46, ranking 33 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 255.50, with a high of 310.00 and a low of 220.00.

Analyst Rating

Based on 28 analysts

Buy

Current Rating

226.837

Target Price

+26.72%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Danaher Corp

DHR

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Forecast

Actual

FAQs

What is Danaher Corp's expected revenue for the next quarter?



Danaher Corp's expected revenue is 6.49B.

What is Danaher Corp's price target?



Analysts forecast that Danaher Corp's price target is USD 255.50, with the highest forecast at USD 310.00 and the lowest forecast at USD 220.00.

How have Danaher CorpDHR's recent earnings per share performed?



The market expectation was USD 1.23, while Danaher CorpDHR's earnings per share (EPS) for the previous quarter was USD 1.45. EPS for the next quarter is expected at USD 1.93.

What is the analyst rating for Danaher Corp?



Based on the ratings of Danaher Corp's stock from 28 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.